Concurrent psychotherapy and pharmacotherapy in the treatment of depression and anxiety in cancer patients
β Scribed by Robert K. Twillman; Corinne Manetto
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 49 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1057-9249
No coin nor oath required. For personal study only.
β¦ Synopsis
Over the past 30 years, numerous studies have compared the relative effectiveness of psychotherapy, pharmacotherapy, and concurrent therapeutic approaches in treatment of common psychiatric disorders, such as depression and anxiety. Generally, these studies have demonstrated that the combined approach is somewhat more effective in treating the disorder in question, as well as in preventing relapse. A number of theories regarding the reasons for this finding have been proposed. The application of this therapeutic approach to the specific population of cancer patients has not been studied in systematic research. This paper briefly reviews the studies comparing the efficacies of various treatment approaches for depression, discusses reasons for the efficacy of such an approach, and outlines a series of reasons why this may be the preferred model for intervening with cancer patients.
π SIMILAR VOLUMES
## A long-standing debate has raged about the relative efficacy of pharmacotherapy and focal psychotherapies (e.g., cognitive and behavioral therapies) in the treatment of panic disorder. Though the controversy continues unabated, data have begun to accumulate which suggest that the focal psychother
## Psychotherapy and pharmacotherapy are each effective in treating borderline personality disorder. In severely symptomatic patients, psychotherapy reduces suicidality and the utilization of inpatient psychiatric care within the first year of treatment, but drop-out rates are high. Pharmacotherapy